Patients with Enterobacter infections experienced similar outcomes when treated with cefepime and carbapenems, according to a study in Clinical Infectious Diseases. Researchers found none of the ...
Add Yahoo as a preferred source to see more of our stories on Google. Custom-built therapy named Entelli-02, a mixture of five carefully selected phages that could one day help save patients’ lives ...
Real-world evidence study carried out in Spain demonstrates 68% clinical cure rate at day 14, and 83% overall survival at day 28, for patients infected with highly resistant metallo-beta lactamase ...
In one of the busiest hospitals in Melbourne, a potentially fatal epidemic of antibiotic-resistant germs compelled physicians and researchers to search for novel weapons. The culprit was the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results